These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37805215)

  • 1. Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trial.
    Kivuyo S; Birungi J; Okebe J; Wang D; Ramaiya K; Ainan S; Tumuhairwe F; Ouma S; Namakoola I; Garrib A; van Widenfelt E; Mutungi G; Jaoude GA; Batura N; Musinguzi J; Ssali MN; Etukoit BM; Mugisha K; Shimwela M; Ubuguyu OS; Makubi A; Jeffery C; Watiti S; Skordis J; Cuevas L; Sewankambo NK; Gill G; Katahoire A; Smith PG; Bachmann M; Lazarus JV; Mfinanga S; Nyirenda MJ; Jaffar S;
    Lancet; 2023 Oct; 402(10409):1241-1250. PubMed ID: 37805215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating HIV, diabetes and hypertension services in Africa: study protocol for a cluster randomised trial in Tanzania and Uganda.
    Mfinanga SG; Nyirenda MJ; Mutungi G; Mghamba J; Maongezi S; Musinguzi J; Okebe J; Kivuyo S; Birungi J; van Widenfelt E; Van Hout MC; Bachmann M; Garrib A; Bukenya D; Cullen W; Lazarus JV; Niessen LW; Katahoire A; Shayo EH; Namakoola I; Ramaiya K; Wang D; Cuevas LE; Etukoit BM; Lutale J; Meshack S; Mugisha K; Gill G; Sewankambo N; Smith PG; Jaffar S
    BMJ Open; 2021 Oct; 11(10):e047979. PubMed ID: 34645657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decentralising chronic disease management in sub-Saharan Africa: a protocol for the qualitative process evaluation of community-based integrated management of HIV, diabetes and hypertension in Tanzania and Uganda.
    Van Hout MC; Akugizibwe M; Shayo EH; Namulundu M; Kasujja FX; Namakoola I; Birungi J; Okebe J; Murdoch J; Mfinanga SG; Jaffar S
    BMJ Open; 2024 Mar; 14(3):e078044. PubMed ID: 38508649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating health services for HIV infection, diabetes and hypertension in sub-Saharan Africa: a cohort study.
    Birungi J; Kivuyo S; Garrib A; Mugenyi L; Mutungi G; Namakoola I; Mghamba J; Ramaiya K; Wang D; Maongezi S; Musinguzi J; Mugisha K; Etukoit BM; Kakande A; Niessen LW; Okebe J; Shiri T; Meshack S; Lutale J; Gill G; Sewankambo N; Smith PG; Nyirenda MJ; Mfinanga SG; Jaffar S
    BMJ Open; 2021 Nov; 11(11):e053412. PubMed ID: 34728457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and health provider costs of integrated HIV, diabetes and hypertension ambulatory health services in low-income settings - an empirical socio-economic cohort study in Tanzania and Uganda.
    Shiri T; Birungi J; Garrib AV; Kivuyo SL; Namakoola I; Mghamba J; Musinguzi J; Kimaro G; Mutungi G; Nyirenda MJ; Okebe J; Ramaiya K; Bachmann M; Sewankambo NK; Mfinanga S; Jaffar S; Niessen LW
    BMC Med; 2021 Sep; 19(1):230. PubMed ID: 34503496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strengthening integration of chronic care in Africa: protocol for the qualitative process evaluation of integrated HIV, diabetes and hypertension care in a cluster randomised controlled trial in Tanzania and Uganda.
    Van Hout MC; Bachmann M; Lazarus JV; Shayo EH; Bukenya D; Picchio CA; Nyirenda M; Mfinanga SG; Birungi J; Okebe J; Jaffar S
    BMJ Open; 2020 Oct; 10(10):e039237. PubMed ID: 33033029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing integrated care clinics for HIV-infection, diabetes and hypertension in Uganda (INTE-AFRICA): process evaluation of a cluster randomised controlled trial.
    Van Hout MC; Zalwango F; Akugizibwe M; Chaka MN; Birungi J; Okebe J; Jaffar S; Bachmann M; Murdoch J
    BMC Health Serv Res; 2023 Jun; 23(1):570. PubMed ID: 37268916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term impact of an integrated HIV/non-communicable disease care intervention on patient retention in care and clinical outcomes in East Africa.
    Namakoola I; Moyo F; Birungi J; Kivuyo S; Karoli P; Mfinanga S; Nyirenda M; Jaffar S; Garrib A
    Trop Med Int Health; 2024 Aug; 29(8):723-730. PubMed ID: 38973259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.
    Mfinanga S; Chanda D; Kivuyo SL; Guinness L; Bottomley C; Simms V; Chijoka C; Masasi A; Kimaro G; Ngowi B; Kahwa A; Mwaba P; Harrison TS; Egwaga S; Jaffar S;
    Lancet; 2015 May; 385(9983):2173-82. PubMed ID: 25765698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a patient-centered hypertension delivery strategy on all-cause mortality: Secondary analysis of SEARCH, a community-randomized trial in rural Kenya and Uganda.
    Hickey MD; Ayieko J; Owaraganise A; Sim N; Balzer LB; Kabami J; Atukunda M; Opel FJ; Wafula E; Nyabuti M; Brown L; Chamie G; Jain V; Peng J; Kwarisiima D; Camlin CS; Charlebois ED; Cohen CR; Bukusi EA; Kamya MR; Petersen ML; Havlir DV
    PLoS Med; 2021 Sep; 18(9):e1003803. PubMed ID: 34543267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial.
    Barnabas RV; Szpiro AA; van Rooyen H; Asiimwe S; Pillay D; Ware NC; Schaafsma TT; Krows ML; van Heerden A; Joseph P; Shahmanesh M; Wyatt MA; Sausi K; Turyamureeba B; Sithole N; Morrison S; Shapiro AE; Roberts DA; Thomas KK; Koole O; Bershteyn A; Ehrenkranz P; Baeten JM; Celum C;
    Lancet Glob Health; 2020 Oct; 8(10):e1305-e1315. PubMed ID: 32971053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acceptability of integrated healthcare services for HIV and non-communicable diseases: experiences from patients and healthcare workers in Tanzania.
    Shayo EH; Kivuyo S; Seeley J; Bukenya D; Karoli P; Mfinanga SG; Jaffar S; Van Hout MC
    BMC Health Serv Res; 2022 May; 22(1):655. PubMed ID: 35578274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial.
    Garrib A; Kivuyo S; Bates K; Ramaiya K; Wang D; Majaliwa E; Simbauranga R; Charles G; van Widenfelt E; Luo H; Alam U; Nyirenda MJ; Jaffar S; Mfinanga S;
    Diabetologia; 2023 Oct; 66(10):1882-1896. PubMed ID: 37460828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania.
    Geldsetzer P; Francis JM; Ulenga N; Sando D; Lema IA; Mboggo E; Vaikath M; Koda H; Lwezaula S; Hu J; Noor RA; Olofin I; Larson E; Fawzi W; Bärnighausen T
    BMC Health Serv Res; 2017 Feb; 17(1):160. PubMed ID: 28228134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial.
    Drain PK; Dorward J; Violette LR; Quame-Amaglo J; Thomas KK; Samsunder N; Ngobese H; Mlisana K; Moodley P; Donnell D; Barnabas RV; Naidoo K; Abdool Karim SS; Celum C; Garrett N
    Lancet HIV; 2020 Apr; 7(4):e229-e237. PubMed ID: 32105625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trial.
    Hoffman RM; Moyo C; Balakasi KT; Siwale Z; Hubbard J; Bardon A; Fox MP; Kakwesa G; Kalua T; Nyasa-Haambokoma M; Dovel K; Campbell PM; Tseng CH; Pisa PT; Cele R; Gupta S; Benade M; Long L; Xulu T; Sanne I; Rosen S
    Lancet Glob Health; 2021 May; 9(5):e628-e638. PubMed ID: 33865471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community delivery of antiretroviral drugs: A non-inferiority cluster-randomized pragmatic trial in Dar es Salaam, Tanzania.
    Geldsetzer P; Francis JM; Sando D; Asmus G; Lema IA; Mboggo E; Koda H; Lwezaula S; Ambikapathi R; Fawzi W; Ulenga N; Bärnighausen T
    PLoS Med; 2018 Sep; 15(9):e1002659. PubMed ID: 30231024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.